In addition to prostate cancer, LSD1 is a key driver in multiple cancers, including Merkel cell carcinoma, acute myeloid leukemia, squamous cell carcinoma, small cell lung cancer, and neuroblastoma (14–17). This evidence concerns the gene KDM1A and small cell lung carcinoma.